spironolactone has been researched along with Benign Intracranial Hypertension in 2 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients with IIH should be evaluated for aldosteronism and considered for spironolactone therapy." | 3.79 | Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism. ( Khalid, H; Khan, MU; Salpietro, V; Weber, KT, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, MU | 1 |
| Khalid, H | 1 |
| Salpietro, V | 1 |
| Weber, KT | 1 |
| Mendonca, E | 1 |
| Albuquerque, L | 1 |
| Jacome, L | 1 |
| Luis, ML | 1 |
| Rosa, FC | 1 |
2 other studies available for spironolactone and Benign Intracranial Hypertension
| Article | Year |
|---|---|
Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism.
Topics: Adolescent; Adult; Aldosterone; Child; Electrolytes; Female; Humans; Hyperaldosteronism; Male; Middl | 2013 |
Pseudotumor cerebri in a patient with Bartter's syndrome and obesity.
Topics: Adolescent; Bartter Syndrome; Female; Hematologic Tests; Humans; Indomethacin; Obesity; Potassium Ch | 1996 |